visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Chimerix, Inc.

    Get Full Access

    Description

    • Led by an experienced antiviral drug development team, Chimerix is developing novel oral antiviral therapeutics with the potential to improve quality of life for patients in multiple settings, including transplant, oncology, acute care and global health. The companys proprietary lipid technology has given rise to two clinical stage compounds, CMX001 and CMX157, which have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. Chimerixs lead compound, CMX001, is a broad spectrum lipid acyclic nucleoside phosphonate that inhibits double-stranded DNA (dsDNA) viruses including cytomegalovirus (CMV), adenovirus, BK virus, herpes simplex virus and variola (smallpox). CMX001 has completed Phase 2 clinical development for the prophylaxis of CMV and is in Phase 2 development for the preemption and treatment of adenovirus infection in hematopoietic stem cell transplant (HSCT) recipients. To date, more than 750 patients have been dosed with CMX001 in controlled clinical trials and open-label treatment protocols. Antiviral activity from completed and ongoing studies, coupled with the lack of myelotoxicity and nephrotoxicity that are associated with currently available therapies, indicate that CMX001 has the potential to improve outcomes for stem cell and solid organ transplant recipients.
    • location

      Headquarters:2505 Meridian Parkway , Durham, North Carolina, United States

      More
    • Chimerix, Inc. phone

      Phone Number: +1 919-806-1074

    • Chimerix, Inc. website

      Website: https://www.chimerix.com

    • Chimerix, Inc. employees

      Employees:68

    • Chimerix, Inc. revenue

      Revenue:$10 - 50M

    • Chimerix, Inc. legal name

      Legal Name:Chimerix, Inc.

    • Chimerix, Inc.'s Social Media

      Chimerix, Inc. linkedin Chimerix, Inc. twitter
    • done Is this data correct?

    • |  NAICS Code: 325412  |

      Show More
    Person level website identification

    CEO for Chimerix, Inc.

    Mike Sherman

    President And Chief Executive Officer, Chimerix

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Randall Lanier

    Chief Science Officer

    Vicki Vakiener

    Board Member

    Odin Naderer

    Vice President Clinical Pharmacology And Translational Medicine

    Tom Brundage

    Vice President, Biostatistics

    Roy Ware

    Vice President, Chemistry

    Frequently Asked Questions regarding Chimerix, Inc.

    • Where are Chimerix, Inc.'s Headquarters?

      Chimerix, Inc.'s Headquarters are in 2505 Meridian Parkway ,Durham,North Carolina,United States

    • What is Chimerix, Inc.'s phone number?

      Chimerix, Inc.'s phone number is +1 919-806-1074

    • What is Chimerix, Inc.'s official website?

      Chimerix, Inc.'s official website is https://www.chimerix.com

    • What is Chimerix, Inc.'s Revenue?

      Chimerix, Inc.'s revenue is $10 - 50M

    • What is Chimerix, Inc.'s NAICS code?

      Chimerix, Inc.'s NAICS code is 325412

    • How many employees are working in Chimerix, Inc.

      Chimerix, Inc. has 68 employees

    • What is Chimerix, Inc.'s Industry?

      Chimerix, Inc. is in the industry of Pharmaceuticals

    • Who is Chimerix, Inc.'s CEO?

      Chimerix, Inc.'s CEO is Mike Sherman

    Company Directory